Drostanolone Propionate 100 mg

Drostanolone Propionate 100 mg/ml — Swiss Remedies

• Brand: Swiss Remedies
• Category: Injectable AAS · DHT-derived anabolic steroid
• Content: 100 mg/ml drostanolone propionate
• Packaging: 10 1 ml ampoules (100 mg per ampoule)
• Origin: Switzerland
• Research Notice: For research, information and collector use only. Not for human or veterinary use.

Product Overview

Drostanolone Propionate is a dihydrotestosterone (DHT)-derived anabolic-androgenic steroid (AAS).

It is non-aromatisable, meaning it does not convert to estrogen, and historically was used as an adjunct therapy for certain types of breast cancer.

In modern research, it is widely studied for its anabolic effects, androgen receptor signalling, and metabolic behaviour.

This product is a short-acting propionate ester, releasing the hormone quickly after intramuscular injection and providing a fast depot cycle suitable for PK/PD research.

Drostanolone is prohibited in all sports under the WADA S1 anabolic agents category and frequently appears in anti-doping investigations.

Key Research Highlights

DHT-derived backbone:

No aromatisation supports research on androgen-only signalling without estrogenic conversion.

Androgen receptor agonist:

Promotes transcription of anabolic genes protein synthesis, nitrogen retention, muscular maintenance.

Propionate ester:

Short-acting ester enabling fast release and rapid blood-level fluctuations ideal for PK modelling.

Anti-estrogenic legacy:

Historic oncology research explored drostanolone for its androgenic and potential anti-estrogenic effects.

Doping & detection science:

Key molecule in steroid-detection development; banned at all times under WADA rules.

Mechanism of Action

• AR binding: High-affinity activation of the androgen receptor anabolic signalling
• DHT-based behaviour: No estrogen conversion different fluid balance profile vs. testosterone
• Propionate ester kinetics: Rapid absorption and clearance relative to enanthate
• Possible anti-estrogenic interplay: Historically studied in estrogen-driven cancers

Scientific Specifications

Field

Data

Active substance

Drostanolone (as Drostanolone Propionate)

Chemical class

Anabolic-androgenic steroid · DHT derivative

Molecular formula

C23H36O2

Molecular weight

360.5 g/mol

Aromatisation

None (non-aromatisable)

Historical use

Adjunct treatment for advanced breast cancer (obsolete)

Doping status

WADA S1 — Prohibited anabolic agent

Route (research context)

Intramuscular (oil-based)

Legal Status

Controlled substance in many jurisdictions

Research Applications

• Androgen receptor signalling & gene transcription studies
• Anabolic-to-androgenic effect comparison across AAS
• Body-composition modelling & fluid-balance studies
• Steroid metabolism and toxicology
• Anti-doping analytical method development

Side Effects / Risks (Class-Based)

• Acne, oily skin, hair loss
• Altered lipids (HDL / LDL), cardiovascular strain
• Suppression of endogenous testosterone
• Fertility impairment
• Mood or behavioural changes
• Pain or irritation at injection site

Compliance & Legal Notice

Drostanolone and its esters are banned at all times by WADA and all major sporting bodies.

Controlled in many countries; unauthorised possession or distribution can be illegal.

FOR RESEARCH USE ONLY. Not a dietary supplement, not a medicine, not for self-administration.

All researchers must follow institutional SOPs, handling protocols and legal requirements.